SFI
RGNX icon

Sonic Fund II’s Regenxbio RGNX Stock Holding History

Sonic Fund II’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-193,079
Closed -$5.1M – 17
2022
Q3 		$5.1M Hold
193,079
– – 3.47% 15
2022
Q2 		$4.77M Hold
193,079
– – 2.91% 16
2022
Q1 		$6.41M Hold
193,079
– – 3.6% 15
2021
Q4 		$6.31M Buy
193,079
+4,293
+2% +$146K 4.09% 14
2021
Q3 		$7.91M Sell
188,786
-75,000
-28% -$2.7M 4.47% 6
2021
Q2 		$10.2M Hold
263,786
– – 4.67% 9
2021
Q1 		$9M Hold
263,786
– – 3.72% 10
2020
Q4 		$12M Hold
263,786
– – 5.78% 4
2020
Q3 		$7.26M Sell
263,786
-151,878
-37% -$4.95M 5.1% 4
2020
Q2 		$15.3M Sell
415,664
-50,000
-11% -$1.86M 7.62% 4
2020
Q1 		$15.1M Hold
465,664
– – 13.06% 2
2019
Q4 		$19.1M Buy
+465,664
New +$18.4M 19.59% 2

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sonic Fund II's RGNX Position: Q4 2022 in Review

Sonic Fund II sold out of Regenxbio (RGNX) in Q4 2022, closing a stake of 193,079 shares — an estimated $5.1M sold.

Sonic Fund II first reported a position in RGNX in Q4 2019 and held it in 12 quarters. The position peaked at $19.1M in Q4 2019. 182 funds tracked by Wall St. Rank hold RGNX as of Q4 2022.

  • Sonic Fund II reported no remaining Regenxbio position as of Q4 2022 after selling out during the quarter.
  • Sonic Fund II sold 193,079 Regenxbio shares in Q4 2022, an estimated $5.1M.
  • Sonic Fund II first reported a position in Regenxbio in Q4 2019 and held it in 12 quarters.
  • Sonic Fund II's Regenxbio position peaked at $19.1M in Q4 2019.
  • 182 funds tracked by Wall St. Rank held Regenxbio as of Q4 2022.

Based on Sonic Fund II's 13F filing for Q4 2022.